Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Dupilumab and COVID-19 can worsen or trigger psoriasis.

The symposium highlighted the importance of genetics in understanding and treating complex skin diseases.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

The skin microenvironment significantly affects hair growth and loss, offering potential treatment avenues.

Patients with cutaneous lupus are most concerned about self-consciousness, physical symptoms, and disease progression.

MicroRNAs play a crucial role in skin and hair health, affecting everything from growth to aging, and could potentially be used in treating skin diseases.

Melasma is a skin condition linked to female hormones, genetics, UV exposure, and certain medications, but not to pituitary, adrenal, or thyroid diseases.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

New understanding and treatments for hair loss are improving, but more research is needed.

Blood pressure drugs can cause skin lupus, but it improves after stopping the drug. The glycoprotein D vaccine works against genital herpes in some women, and the HPV-16 vaccine reduces HPV-16 infection and related diseases. More frequent light therapy clears psoriasis faster. A cream called imiquimod effectively treats a type of skin cancer. Iron supplements don't necessarily help with chronic hair loss in women.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

The peptide GHK-Cu helps heal and remodel tissue, improves skin and hair health, and has potential for treating age-related inflammatory diseases.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

COVID-19 vaccination may trigger lupus in some people.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Alopecia Areata is linked to a higher risk of several diseases, which vary with age and sex.

Stress may trigger hair loss by affecting immune protection in hair follicles.

The 2012 criteria are better for diagnosing atypical lupus cases.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

ATR-FTIR spectroscopy could help monitor alopecia areata treatment response non-invasively.

Oral betamethasone mini-pulses effectively treat moderate to severe alopecia areata with manageable side effects.

Hydroxychloroquine may help delay skin damage in lupus patients.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Nanoparticles improve skin treatment but need more research on safety and effectiveness.

Men with androgenetic alopecia may have higher blood pressure, suggesting early screening for hypertension.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.